Inhibitors of glutathione S-transferases as therapeutic agents

Advanced Drug Delivery Reviews

Volumn 26, Issue 2-3, 1997, Pages 91-104

  Schultz, Mary ^a   Dutta, Seema ^a   Tew, Kenneth D ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Alkylating agents; Drug resistance; Ethacrynic acid; Modulation; TER 199; TER 286

Indexed keywords

AGENTS; CATALYSIS; DRUG THERAPY; GENES; SOLUBILITY;

ALKYLATING AGENTS; ETHACRYNIC ACID; GLUTATHIONE TRANSFERASES;

ENZYME INHIBITION;

ALKYLATING AGENT; ANTINEOPLASTIC AGENT; CANFOSFAMIDE; CARMUSTINE; CHLORAMBUCIL; CHLORMETHINE; CYCLOPHOSPHAMIDE; DACARBAZINE; DIAZIQUONE; ENZYME INHIBITOR; ETACRYNIC ACID; GAMMA GLUTAMYL S BENZYLCYSTEINYLPHENYLGLYCINE DIETHYL ESTER; GLUTATHIONE; GLUTATHIONE TRANSFERASE; IFOSFAMIDE; LOMUSTINE; MELPHALAN; NIMUSTINE; PROCARBAZINE; PRODRUG; THIOTEPA; UNCLASSIFIED DRUG;

CANCER; CANCER RESISTANCE; ENZYME SPECIFICITY; HUMAN; MODULATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

EID: 0031558238     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(97)00029-X     Document Type: Review

References (110)

1. W.B. Pratt, R.W. Ruddon, W.D. Ensminger, J. Maybaum, The Anticancer Drugs, Oxford University Press, New York, 1994.
2. G.J. Goldenberg, A. Begleiter, Alterations in drug transport, in: B.W. Fox. M. Fox (Eds.), Handbook of Experimental Pharmacology: Antitumor Drug Resistance, Springer, New York, 1988, pp. 198-241.
3. M.M. Gottesman, I. Pastan, The multidrug transporter, a double-edged sword, J. Biol. Chem. 263 (1988) 12163-12166.
4. S.P.C. Cole, G. Bhardwai, J.H. Gerlach, J.E. Mackie, C.E. Grant, K.C. Almquist, A.J. Stewart, E.U. Kurz, A.M.V. Duncan, R.G. Deeley, Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line, Science 258 (1992) 1650-1654.
5. J. Hilton, Role of aldehyde dehydrogenase in cyclophosphamide-resistant L1210 leukemia, Cancer Res. 44 (1984) 5156-5160.
6. A.L. Wang, K.D. Tew, Increased glutathione S-transferase activity in a cell line with acquired resistance to nitrogen mustards, Cancer Treat. Rep. 69 (1985) 677-682.
7. R.T. Schimke, Gene amplification in cultured animal cells, Cell 37 (1984) 705-713.
8. 6-alkylguanine, FASEB J. 6 (1992) 2302-2310.
9. K. Suzukake, B.J. Petro, D.T. Vistica, Reduction in glutathione content of L-PAM resistant L1210 cells confers drug sensitivity, Biochem. Pharmacol. 31 (1982) 121-124.
10. K.D. Tew, P.J. Houghton, J.A. Houghton, Preclinical and Clinical Modulation of Anticancer Drugs, CRC Press, Boca Raton, FL, 1993, pp. 13-77.
11. J.D. Hayes, D.J. Pulford, The glutathione S-transferase supergene family: regulation of GST and the contribution of the isozymes to cancer chemoprotection and drug resistance, Crit. Rev. Biochem. Mol. Biol. 30 (1995) 445-600.
12. K.D. Tew, A. Monks, L. Barone, D. Rosser, G. Akerman, J.A. Montali, J.B. Wheatley, D.E. Schmidt, Glutathione-associated enzymes in the human cell lines of the National Cancer Institute drug screening program, Mol. Pharmacol. 50 (1996) 149-159.
13. A. Kitahara, K. Satoh, K. Nishimura, T. Ishikawa, K. Ruike, K. Sato, H. Tsuda, N. Ito, Changes in molecular forms of rat hepatic glutathione S-transferase during chemical hepatocarcinogenesis, Cancer Res. 44 (1984) 2698-2703.
14. H. Jensson, L.C. Eriksson, B. Mannervik, Selective expression of glutathione transferase isoenzymes in chemically induced preneoplastic rat hepatocyte nodules, FEBS Lett. 187 (1985) 115-120.
15. C. DiIlio, G. Del Boccio, A. Aceto, R. Casaccia, F. Mucilli, G. Federici, Elevation of glutathione transferase activity in human lung tumor, Carcinogenesis 9(2) (1988) 335-340.
16. A.F. Howie, L.M. Forrester, M.J. Glancey, J.J. Schlager, G. Powis, J.D. Hayes, C.R. Wolf, Glutathione S-transferase and glutathione peroxidase expression in normal and tumor human tissues, Carcinogenesis 11(3) (1990) 451-458.
17. H. Eimoto, M. Tsutsumi, A. Nakajima, K. Yamamoto, Y. Takashima, H. Maruyama, Y. Konishi, Expression of the glutathione S-transferase placental form in human lung carcinomas, Carcinogenesis 9 (1988) 2325-2327.
18. S. Ranganathan, K.D. Tew, Immunohistochemical localization of glutathione S-transferases α, μ and π in normal and tumor tissue from human colon, Carcinogeneis 12 (1991) 2383-2387.
19. C. DiIlio, G. Del Boccio, A. Aceto, G. Federici, Alteration of glutathione transferase isoenzyme concentrations in human renal carcinomas, Carcinogenesis 8 (1987) 861-864.
20. D.J. Harrison, R. Kharbanda, D. Bishop, L.I. McLellan, J.D. Hayes, Glutathione S-transferase isoenzymes in human renal carcinoma demonstrated by immunohistochemistry, Carcinogenesis 10 (1989) 1257-1260.
21. Y. Shiratori, Y. Soma, H. Maruyama, S. Sato, A. Takano, K. Sato, Immunohistochemical detection of the placental form of glutathione S-transferase in dysplastic and neoplastic human uterine cervix lesions, Cancer Res. 47 (1987) 6806-6809.
22. J.A. Moscow, R.R. Fairchild, M.J. Madden, D.T. Ransom, H.S. Wieand, E.E. O'Brien, D.G. Poplack, J. Cossman, C.E. Myers, K.H. Cowan, Expression of anionic glutathione S-transferase and P-glycoprotein genes in human tissues and tumors, Cancer Res. 49 (1989) 1422-1428.
23. J.C. Schisselbauer, R. Silber, E. Papadopoulos, K. Abrams, F.P. LaCreta, K.D. Tew, Characterization of glutathione S-transferase expression in lymphocytes from chronic lymphocytic leukemia patients, Cancer Res. 50 (1990) 3562-3568.
24. A.D. Lewis, J.D. Hayes, C.R. Wolf, Glutathione and glutathione-dependent enzymes in ovarian adenocarcinoma cell lines derived from a patient before and after the onset of drug resistance: intrinsic differences and cell cycle effects, Carcinogenesis 9 (1988) 1283-1287.
25. S.-I. Hamada, M. Kamada, H. Furumoto, T. Hirao, T. Aono, Expression of glutathione S-transferase π in human ovarian cancer as an indicator of resistance to chemotherapy, Gynecol. Oncol. 52 (1994) 313-319.
26. U. Tidefelt, A. Elmhorn-Rosenborg, C. Paul, X.-Y. Hao, B. Mannervik, L.C. Eriksson, Expression of glutathione transferase π as a predictor for treatment results at different stages of acute nonlymphoblastic leukemia, Cancer Res. 52 (1992) 3281-3285.
27. M.J. Tisdale, B.J. Phillips, Alterations in adenosine 3′,5′-monophosphate-binding protein in Walker carcinoma cells sensitive or resistant to alkylating agents, Biochem. Pharmacol. 25 (1976) 1831-1836.
28. C.J. Wareing, S.M. Black, J.D. Hayes, C.R. Wolf, Increased levels of alpha-class and pi-class glutathione S-transferases in cell lines resistant to 1-chloro-2,4-dinitrobenzene, Eur. J. Biochem. 217 (1993) 671-676.
29. A.L. Buller, M.L. Clapper, K.D. Tew, Glutathione S-transferases in nitrogen mustard-resistant and -sensitive cell lines, Mol. Pharmacol. 31 (1987) 575-578.
30. C.N. Robson, A.D. Lewis, C.R. Wolf, J.D. Hayes, A. Hall, S.J. Proctor, A.L. Harris, I.D. Hickson, Reduced levels of drug-induced DNA cross-linking in nitrogen mustard-resistant Chinese hamster ovary cells expressing elevated glutathione S-transferase activity, Cancer Res. 47 (1987) 6022-6027.
31. A.D. Lewis, I.D. Hickson, C.N. Robson, A.L. Harris, J.D. Hayes, S.A. Griffiths, M.M. Manson, A.E. Hall, J.E. Mos, C.R. Wolf, Amplification and increased expression of alpha class glutathione S-transferase-encoding genes associated with resistance to nitrogen mustards, Proc. Natl. Acad. Sci. USA 85 (1988) 8511-8515.
32. A.T. McGowan, B.W. Fox, A proposed mechanism of resistance to cyclophosphamide and phosphoramide mustard in a Yoshida cell line in vitro, Cancer Chemother. Pharmacol. 17 (1986) 223-226.
33. C.G. Evans, W.J. Bodell, K. Tokuda, P. Doane-Setzer, M.T. Smith, Glutathione and related enzymes in rat brain tumor cell resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea and nitrogen mustard, Cancer Res. 47 (1987) 2525-2530.
34. V. Gupta, S.V. Singh, H. Ahmad, R.D. Medh, Y.C. Awasthi, Glutathione and glutathione S-transferases in a human plasma cell line resistant to melphalan, Biochem. Pharmacol. 38 (1989) 1993-2000.
35. T.H. Manoharan, R.B. Puchalski, J.A. Burgess, C.B. Pickett, W.E. Fahl, Promoter-Glutathione S-transferase Ya cDNA hybrid genes, J. Biol. Chem. 262 (1987) 3739-3745.
36. R.B. Puchalski, W.E. Fahl, Expression of recombinant glutathione S-transferase π, Ya, or Yb1 confers resistance to alkylating agents, Proc. Natl. Acad. Sci. USA 87 (1990) 2443-2447.
37. S.M. Black, J.D. Beggs, J.D. Hayes, A. Bartoszek, M. Muramatsu, M. Sakai, C.R. Wolf, Expression of human glutathione S-transferases in Saccharomyces cerevisiae confers resistance to the anticancer drugs adriamycin and chlorambucil, Biochem. J. 268 (1990) 309-315.
38. R.L. Schecter, M.A. Alaoui-Jamali, A. Woo, W.E. Fahl, G. Batist, Expression of a rat glutathione S-transferase complementary DNA in rat mammary carcinoma cells: impact upon alkylator-induced toxicity, Cancer Res. 53 (1993) 4900-4906.
39. M. Greenbaum, S. Letourneau, H. Assar, R.L. Schecter, G. Batist, D. Cournoyer, Retrovirus-mediated gene transfer of rat glutathione S-transferase Yc confers alkylating drug resistance in NIH 3T3 mouse fibroblasts. Cancer Res. 54 (1994) 4442-4447.
40. N. Ban, Y. Takahashi, T. Takayama, T. Kura, T. Katahara, S. Sakomaki, Y. Nitsu, Transfection of glutathione S-transferase (GST)-π antisense complementary DNA increases the sensitivity of a colon cancer cell line to adriamycin, cisplatin, melphalan, and etoposide, Cancer Res. 56 (1996) 3577-3582.
41. J.A. Moscow, A.J. Townsend, K.H. Cowan, Elevation of π class glutathione S-transferase activity in human breast cancer cells by transfection of the GST π gene and its effect on sensitivity to toxins, Mol. Pharmacol. 36 (1989) 22-28.
42. B.R. Leyland-Jones, A.J. Townsend, C.-P.D. Tu, K.H. Cowan, M.E. Goldsmith, Antineoplastic drug sensitivity of human MCF-7 breast cancer cells stably transfected with a human α class glutathione S-transferase gene, Cancer Res. 51 (1991) 587-594.
43. A.J. Townsend, C.-P.D. Tu, K.H. Cowan, Expression of human m or a class glutathione S-transferases in stably transfected human MCF-7 breast cancer cells: effect on cellular sensitivity to cytotoxic agents, Mol. Pharmacol. 41 (1991) 230-236.
44. D.M. Dulik, C. Fenselau, J. Hilton, Characterization of melphalan-glutathione adducts whose formation is catalyzed by glutathione transferases, Biochem. Pharmacol. 35 (1986) 3405-3409.
45. M.G. Bolton, O.M. Colvin, J. Hilton, Specificity of isozymes of murine hepatic glutathione S-transferase for the conjugation of glutathione with L-phenylalanine mustard, Cancer Res. 51 (1991) 2410-2415.
46. P.J. Ciaccio, K.D. Tew, F.P. LaCreta, Enzymatic conjugation of chlorambucil with glutathione by human glutathione S-transferases and inhibition by ethacrynic acid, Biochem. Pharmacol. 42 (1991) 1504-1507.
47. P.J. Ciaccio, K.D. Tew, F.P. LaCreta, The spontaneous and glutathione S-transferase-mediated reaction of chlorambucil with glutathione, Cancer Commun. 2 (1990) 279-286.
48. D.J. Meyer, K.S. Gilmore, J.M. Harris, J.A. Hartley, B. Ketterer, Chlorambucil-monoglutathionyl conjugate is sequestered by human alpha class glutathione S-transferases, Br. J. Cancer 66 (1992) 433-438.
49. M.P. Gamcsik, T.G. Hamill, O.M. Colvin, NMR studies of conjugation of mechlorethamine with glutathione, J. Med. Chem. 33 (1990) 1009-1014.
50. Z.-M. Yuan, P.B. Smith, R.B. Brundrett, M. Colvin, C. Fenselau, Glutathione conjugation with phosphoramide mustard and cyclophosphamide, Drug Metab. Dispos. 19 (1991) 625-629.
51. H.A.A.M. Dirven, B. van Ommen, P.J. van Bladeren, Involvement of human glutathione S-transferase isoenzymes in the conjugation of cyclophosphamide metabolites with glutathione, Cancer Res. 54 (1994) 6215-6220.
52. F.Y.F. Lee, Glutathione diminishes the anti-tumour activity of 4-hydroperoxycyclophosphamide by stablising its spontaneous breakdown to alkylating metabolites, Br. J. Cancer 63 (1990) 45-52.
53. K. Berhane, B. Mannervik, Inactivation of the genotoxic aldehyde acrolein by human glutathione transferases of classes alpha, mu, and pi, Mol. Pharmacol. 37 (1989) 251-254.
54. M.T. Smith, C.G. Evans, P. Doane-Setzer, V.M. Castro, M.K. Tahir, B. Mannervik, Denitrosation of 13-bis(2-chloroethyl)-1-nitrosourea by class mu glutathione transferases and its role in cellular resistance in rat brain tumor cells, Cancer Res. 49 (1989) 2621-2625.
55. K. Berhane, X.-Y. Hao, S. Egyhazi, J. Hansson, U. Ringborg, B. Mannervik, Contribution of glutathione transferase M3-3 to 1,3-bis(2-chloroethyl)-1-nitrosourea resistance in a human non-small lung cancer cell line, Cancer Res. 53 (1993) 4257-4261.
56. H.A.A.M. Dirven, E.L.J.T. Dictus, N.L.H.L. Broeders, B.V. van Ommen, P.J. van Bladeren, The role of human glutathione S-transferase isoenzymes in the formation of glutathione conjugates of the alkylating cytostatic drug thiotepa, Cancer Res. 55 (1995) 1701-1706.
57. K.D. Tew, Glutathione-associated enzymes in anticancer drug resistance, Cancer Res. 54 (1994) 4313-4320.
58. M.G. Bolton, J. Hilton, K.D. Robertson, R.T. Streeper, O.M. Colvin, D.A. Noe, Kinetic analysis of the reaction of melphalan with water, phosphate, and glutathione, Drug Metab. Dispos. 21 (1993) 986-996.
59. L.J. Lash, D.P. Jones, Renal glutathione transport. Characteristics of the sodium-dependent system in the basal-lateral membrane, J. Biol. Chem. 259 (1984) 14508-14514.
60. M.T. Vincenzi, F. Favilli, M. Stio, J. Iantomasi, Intestinal glutathione transport system: a possible detoxication role, Biochim. Biophys. Acta 1073 (1991) 571-579.
61. T. Ishikawa, The ATP-dependent glutathione S-conjugate export pump, Trends Biochem. Sci. 17 (1992) 463-468.
62. G. Jedlitschky, I. Leiter, U. Buchholz, M. Center, D. Keppler, ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein, Cancer Res. 54 (1994) 4833-4836.
63. J.T. Ahokas, F.A. Nicholls, P.J. Ravenscroft, B.T. Emmerson, Inhibition of purified rat liver glutathione S-transferase isozymes by diuretic drugs, Biochem. Pharmacol. 34 (1985) 2157-2161.
64. W.H. Habig, M.J. Pabst, W.B. Jakoby, Glutathione S-transferases. The first enzymatic step in mercapturic acid formation, J. Biol. Chem. 249 (1974) 7130-7139.
65. J.T. Ahokas, F.A. Nicholls, P.J. Ravenscroft, B.T. Emmerson, Inhibition of purified rat liver glutathione S-transferase isozymes by diuretic drugs, Biochem. Pharmacol. 34 (1985) 2157-2161.
66. J.H.T.M. Ploemen, B. van Ommen, P.J. van Bladeren, Inhibition of rat and human glutathione S-transferase isoenzymes by ethacrynic acid and its glutathione conjugate, Biochem. Pharmacol. 40 (1990) 1631-1635.
67. K.D. Tew, A.M. Bomber, S.J. Hoffman, Ethacrynic acid and piriprost as enhancers of cytotoxicity in drug resistant and sensitive cell lines, Cancer Res. 48 (1988) 3622-3625.
68. J. Hansson, K. Berhane, V.M. Castro, U. Jungnelius, B. Mannervik, U. Ringborg, Sensitization of human melanoma cells to the cytotoxic effect of melphalan by the glutathione transferase inhibitor ethacrynic acid, Cancer Res. 51 (1991) 94-98.
69. C.G. Evans, W.J. Bodell, K. Tokuda, P. Doane-Setzer, M.T. Smith, Glutathione and related enzymes in rat brain tumor cell resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea and nitrogen mustard, Cancer Res. 47 (1987) 2525-2530.
70. B.H. Xu, S.V. Singh, Effect of buthionine sulfoximine and ethacrynic acid on cytotoxic activity of mitomycin C analogues BMY 25282 and BMY 25067, Cancer Res. 52 (1992) 6666-6670.
71. R.A. Nagourney, J.C. Messenger, D.H. Kern, L.M. Weisenthal, Enhancement of anthracycline and alkylator cytotoxicity by ethacrynic acid in primary cultures of human tissues, Cancer Chemother. Pharmacol. 26 (1990) 318-322.
72. M.L. Clapper, S.J. Hoffman, K.D. Tew, Sensitization of human colon tumor xenografts to L-phenylalanine mustard using ethacrynic acid, J. Cell. Pharmacol. 1 (1990) 71-78.
73. P.J. O'Dwyer, F. LaCreta, S. Nash, P.W. Tinsley, R. Schilder, M.L. Clapper, K.D. Tew, L. Panting, S. Litwin, R.L. Comis, R.F. Ozols, Phase I study of thiotepa in combination with the glutathione transferase inhibitor ethacrynic acid, Cancer Res. 51 (1991) 6059-6065.
74. M. Petrini, A. Conte, F. Caracciolo, A. Sabbatini, B. Grassi, G. Ronca, Reversing of chlorambucil resistance by ethacrynic acid in a B-CLL patient, Br. J. Haematol. 85 (1993) 409-410.
75. S. Kuzmich, L.A. Vanderveer, E.S. Walsh, F.P. LaCreta, K.D. Tew, Increased levels of glutathione S-transferase π transcript as a mechanism of resistance to ethacrynic acid, Biochem. J. 281 (1992) 219-224.
76. A.E.P. Adang, J. Burssee, A. Van der Gen, G.J. Mulder, The glutathione-binding site in glutathione S-transferases, Biochem. J. 269 (1990) 47-54.
77. J.E. Flatgaard, K.E. Bauer, L.M. Kauvar, Isozyme specificity of novel glutathione-S-tranferase inhibitors, Cancer Chemother. Pharmacol. 33 (1993) 63-70.
78. H. Dirr, P. Reinemer, R. Huber, X-ray crystal structures of cytosolic glutathione S-transferases. Implications for protein architecture, substrate recognition and catalytic function, Eur. J. Biochem. 220 (1994) 645-661.
79. G. Stenberg, P.G. Board, B. Mannervik, Mutation of an evolutionarily conserved tyrosine residue in the active site of a human class alpha glutathione transferase, FEBS Lett. 293 (1991) 153-155.
80. K.-H. Kong, M. Nishida, H. Inoue, K. Takahashi, Tyrosine-7 is an essential residue for the catalytic activity of human class pi glutathione transferase: chemical modification and site-directed mutagenesis studies, Biochem. Biophys. Res. Commun. 182 (1992) 1122-1129.
81. T.H. Manoharan, A.M. Gulick, P Reinemer, H.W. Dirr, R. Huber, W.E. Fahl, Mutational substitution of residues implicated by crystal structure in binding the substrate glutathione to human glutathione S-transferases, J. Mol. Biol. 226 (1992) 319-322.
82. S. Liu, P Zhang, X. Ji, W.W. Johnson, G.L. Gilliland, R.N. Armstrong, Contribution of tyrosine 6 to the catalytic mechanism of isozyme 3-3 of glutathione S-transferase, J. Biol. Chem. 267 (1992) 4296-4299.
83. C.J. Penington, G.S. Rule, Mapping the substrate binding site of a human class mu glutathione transferase using nuclear magnetic resonance spectroscopy, Biochemistry 31 (1992) 2912-2920.
84. R.W. Wang, D.J. Newton, S.-E.W. Huskey, B.M. McKeever, C.B. Pickett, A.Y.H. Lu, Site-directed mutagenesis of glutathione S-transferase YaYa. Important roles of tyrosine 9 and aspartic acid 101 in catalysis, J. Biol. Chem. 267 (1992) 19866-19871.
85. R.H. Kolm, G.E. Sroga, B. Mannervik, Participation of the phenolic hydroxyl group of Try-8 in the catalytic mechanism of human glutathione transferase P1-1, Biochem. J. 285 (1992) 537-540.
86. T.H. Manoharan, A.M. Gulick, R.B. Puchalski, A.L. Servias, W.E. Fahl, Structural studies of human glutathine S-transferase π. Substitution mutations to determine amino acid necessary for binding glutathione, J. Biol. Chem. 267 (1992) 18940-18945.
87. G. Stenberg, P.G. Board, I. Carlberg, B. Mannervik, Effects of directed mutagenesis on conserved arginine residues in a human class alpha glutathione transferase, Biochem. J. 274 (1992) 549-555.
88. M. Widersten, R.H. Kolm, R. Bjornestedt, B. Mannervik, Contribution of five amino acid residues in the glutathione-binding site to the function of human glutathione transferase P1-1, Biochem. J. 285 (1992) 377-381.
89. K.-H. Kong, H. Inoue, K. Takahashi, Site-directed mutagenesis of amino acid residues involved in the glutathione binding of human glutathione S-transferase P1-1, J. Biochem. (Tokyo) 112 (1992) 725-728.
90. K.-H. Kong, H. Inoue, K. Takahashi, Site-directed mutagenesis study of the roles of evolutionally, conserved aspartic acid residues in human glutathione S-transferase P1-1, Protein Eng. 6 (1992) 93-99.
91. A.E.P. Adang, A.J.G. Duindam, J. Brussee, G.J. Mulder, A. van der Gen, Synthesis and nucleophilic reactivity of a series of glutathione analogues modified at the gamma-glutamyl moiety, Biochem. J. 255 (1988) 715-720.
92. A.E.P. Adang, J. Brussee, D.J. Meyer, B. Coles, B. Ketterer, A. van der Gen, G.J. Mulder, Substrate specificity of rat liver glutathione S-transferase isozymes for a series of glutathione analogues modified at the gamma-glutamyl moiety, Biochem. J. 255 (1988) 759-764.
93. A.E.P. Adang, J. Brussee, A. van der Gen, G.J. Mulder, The glutathione binding site in glutathione S-transferases. Investigation of the cysteinyl, glycyl and γ-glutamyl domains, Biochem. J. 269 (1990) 47-54.
94. M.H. Lyttle, M.D. Hocker, H.C. Hui, C.G. Caldwell, D.T. Aaron, A. Engqvist-Goldstein, J.E. Flatgaard, K.E. Bauer, Isozyme specific glutathione-S-transferase inhibitors: design and synthesis, J. Med. Chem. 37 (1994) 189-194.
95. A.S. Morgan, P.J. Ciaccio, K.D. Tew, L.M. Kauvar, Isozyme-specific, glutathione S-transferase inhibitors potentiate drug sensitivity in cultured human cell lines, Cancer Chemother. Pharmacol. 37 (1996) 363-370.
96. P.J. Ciaccio, H. Shen, A.K. Jaiswal, M.H. Lyttle, K.D. Tew, Modulation of detoxification gene expression in human colon HT29 cells by glutathione-S-transferase inhibitors, Mol. Pharmacol. 48 (1995) 639-647.
97. M.H. Lyttle, A. Satyam, M.D. Hocker, K.E. Bauer, C.G. Caldwell, H.C. Hui, A.S. Morgan, A. Mergia, L. Kauvar, Glutathione S-tranferases activates novel alkylating agents, J. Med. Chem. 37 (1994) 1501-1507.
98. X. Ji, P. Zhang, R. Armastrong, G. Gilliland, The three dimensional structure of a glutathione-S-transferase from the mu gene class. Structural analysis of the binary complex of isozyme 3-3 and glutathione at 2.2 Å resolution, Biochemistry 31 (1992) 10169-10184.
99. P. Reinemer, H. Dirr, R. Ladenstein, R. Huber, M. Lo Bello, G. Federici, M. Parker, Three dimensional structure of class π glutathione S-tranferase from human placenta in complex with S-hexyl glutathione at 2.8 A resolution, J. Mol . Biol. 227 (1992) 214-226.
100. L.M. Kauvar, GST-targeted drug candidates, in: N.P.E. Vermeulen, G.J. Mulder, H. Nieuwenhuyse, W.H.M. Peters, P.J. Bladeren (Eds.), Glutathione S-transferases. Structure, Function and Clinical Implications, Taylor & Francis Inc., Bristol, PA, 1996, pp. 187-197.
101. B. Honore, H. Leffers, P. Madsen, H.H. Rasmusen, J. Vandekerckhove, J.E. Celis, Molecular cloning and expression of a transforming-sensitive human protein containing the TPR motif and sharing identity to the stress-inducible yeast protein STI1, J. Biol. Chem. 267 (1992) 8485-8491.
102. H. Shen, S. Ranganathan, S. Kuzmich, K.D. Tew, The influence of ethacrynic acid on glutathione S-transferase π transcript and protein half-lives in human colon cancer cells, Biochem. Pharmacol. 50 (1995) 1233-1238.
103. Y. Wang, B.A. Teicher, T.C. Shea, S.A. Holden, K.W. Rosbe, A. Al-Achi, W.D. Henner, Cross-resistance and glutathione S-transferase-π among four human melanoma cell lines selected for alkylating agent resistance, Cancer Res. 49 (1989) 6185-6192.
104. A. Follot, D. Touchard, C. Celler, Impairment of hepatic glutathione S-transferase activity as a cause of reduced biliary sufobromophthalen excretion in clofibate-treated rats, Biochem. Pharmacol. 33 (1984) 2829-2834.
105. V.M. Castro, M.K. Kelley, A. Engqvist-Goldstein, L.M. Kauvar, Glutathione analogue sorbents selectively bind glutathione S-transferase isoenzymes, Biochem. J. 292 (1993) 373-377.
106. J.M. Ford, W.N. Hait, S.A. Matlin, C.C. Benz, Modulation of resistance to alkylating agents in cancer cells by gossysol enantomers, Cancer Lett. 56 (1991) 85-94.
107. A. Hall, C.N. Robson, I.D. Hickson, A.L. Harris, S.J. Proctor, A.R. Cattan, Possible role of inhibition of glutathione S-transferase in the partial reversal of chlorambucil resistance by indomethacin in a Chinese hamster ovary cell line, Cancer Res. 49 (1989) 6265-6268.
108. K.S. Kumar, J.F. Weiss, Inhibition of glutathione peroxidase and glutathione transferase in mouse liver by misonidazole, Biochem. Pharmacol. 35 (1986) 3143-3146.
109. V. Gupta, J.P. Jani, S. Jacobs, M. Levitt, L. Fields, S. Awasthi, B.H. Xu, M. Sreevardhan, Y.C. Awasthi, S.V. Singh, Activity of melphalan in combination with the glutathione transferase inhibitor sulfasalazine, Cancer Chemother. Pharmacol. 36 (1995) 13-19.
110. S. Awasthi, R. Sharma, S.S. Singhal, N.K. Herzog, M. Chaubey, Y.C. Awasthi, Modulation of cisplatin cytotoxicity by sulphsalazine, Br. J. Cancer 70 (1994) 190-194.